Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

Gilles Andrier, CEO of Givaudan discusses HY earnings, and outlines areas of growth within the business despite ongoing ...

Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...

Coca-Cola is less exposed to the U.S. market’s weakness in snacks and soda, compared with other food and beverage companies.

The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...

Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, discusses the importance ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

Survey by PCRM reveals confusion about weight loss drugs, with interest in plant-based diets as safer alternative.